IRIDEX Corporation is a worldwide provider of therapeutic-based laser systems and delivery devices used to treat eye diseases in ophthalmology and skin conditions in dermatology (also referred to as aesthetics). The Company’s products are sold in the United States predominantly through a direct sales force and internationally through approximately 100 independent distributors into 107 countries. The Company operates in two segments: ophthalmology and aesthetics. The Company’s ophthalmology products consist of laser systems, delivery devices, and laser probes and are used in the treatment of eye diseases, including diabetic retinopathy, glaucoma and age-related macular degeneration (AMD). Its aesthetics business focuses primarily on pigmented and vascular lesions, skin rejuvenation, skin tightening, hair reduction, leg veins, and acne.